RedShift BioAnalytics

RedShift BioAnalytics provides an infrared technology with advanced data analysis capabilities, promoting better and faster decision-making throughout the biopharmaceutical development process from discovery to market by directly measuring previously undetectable changes in protein structural attributes that are crucial for drug efficacy and quality. The company has developed a Microfluidic Modulation Spectroscopy (MMS) platform in response to customer demands for improved solutions, rather than repurposing outdated tools and methods initially designed for other applications.